Confluence Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-27,434
| Closed | -$1.26M | – | 303 |
|
|
2020
Q4 | $1.26M | Sell |
27,434
-2,795
| -9% | -$128K | 0.02% | 198 |
|
|
2020
Q3 | $1.42M | Sell |
30,229
-2,211
| -7% | -$111K | 0.02% | 189 |
|
|
2020
Q2 | $1.65M | Sell |
32,440
-1,768
| -5% | -$90.7K | 0.03% | 180 |
|
|
2020
Q1 | $1.62M | Sell |
34,208
-107,874
| -76% | -$5.75M | 0.03% | 179 |
|
|
2019
Q4 | $7.11M | Buy |
142,082
+8,696
| +7% | +$484K | 0.11% | 122 |
|
|
2019
Q3 | $7.12M | Sell |
133,386
-8,696
| -6% | -$447K | 0.11% | 117 |
|
|
2019
Q2 | $7.11M | Sell |
142,082
-250,954
| -64% | -$12.6M | 0.11% | 122 |
|
|
2019
Q1 | $20.5M | Sell |
393,036
-120,219
| -23% | -$6.01M | 0.35% | 74 |
|
|
2018
Q4 | $24.5M | Sell |
513,255
-204,753
| -29% | -$10.1M | 0.46% | 58 |
|
|
2018
Q3 | $36.1M | Sell |
718,008
-437,877
| -38% | -$22.2M | 0.61% | 51 |
|
|
2018
Q2 | $58.2M | Sell |
1,155,885
-109,773
| -9% | -$5.53M | 1.02% | 37 |
|
|
2018
Q1 | $61.8M | Sell |
1,265,658
-34,576
| -3% | -$1.61M | 1.14% | 34 |
|
|
2017
Q4 | $57.6M | Sell |
1,300,234
-328,316
| -20% | -$15.2M | 1.05% | 35 |
|
|
2017
Q3 | $82.6M | Buy |
1,628,550
+84,072
| +5% | +$4.27M | 1.58% | 23 |
|
|
2017
Q2 | $83.2M | Buy |
1,544,478
+112,331
| +8% | +$5.99M | 1.69% | 18 |
|
|
2017
Q1 | $75.5M | Buy |
1,432,147
+200,273
| +16% | +$10.2M | 1.68% | 22 |
|
|
2016
Q4 | $59.3M | Buy |
1,231,874
+108,928
| +10% | +$5.38M | 1.44% | 28 |
|
|
2016
Q3 | $60.5M | Buy |
1,122,946
+58,152
| +5% | +$3.19M | 1.58% | 24 |
|
|
2016
Q2 | $57.7M | Buy |
1,064,794
+117,460
| +12% | +$6.19M | 1.59% | 18 |
|
|
2016
Q1 | $48M | Buy |
947,334
+102,090
| +12% | +$5.08M | 1.44% | 27 |
|
|
2015
Q4 | $42.6M | Buy |
845,244
+59,891
| +8% | +$3.05M | 1.39% | 28 |
|
|
2015
Q3 | $37.7M | Buy |
785,353
+38,379
| +5% | +$2M | 1.38% | 27 |
|
|
2015
Q2 | $38.9M | Buy |
746,974
+56,439
| +8% | +$3.18M | 1.42% | 28 |
|
|
2015
Q1 | $39.8M | Buy |
690,535
+81,115
| +13% | +$4.65M | 1.51% | 22 |
|
|
2014
Q4 | $32.6M | Buy |
609,420
+42,414
| +7% | +$2.37M | 1.33% | 29 |
|
|
2014
Q3 | $32.6M | Buy |
567,006
+43,631
| +8% | +$2.67M | 1.45% | 21 |
|
|
2014
Q2 | $35M | Buy |
523,375
+33,916
| +7% | +$2.3M | 1.6% | 15 |
|
|
2014
Q1 | $32.7M | Buy |
489,459
+43,965
| +10% | +$2.97M | 1.66% | 12 |
|
|
2013
Q4 | $29.7M | Buy |
445,494
+48,488
| +12% | +$3.14M | 1.64% | 15 |
|
|
2013
Q3 | $24.9M | Buy |
397,006
+37,734
| +11% | +$2.43M | 1.54% | 14 |
|
|
2013
Q2 | $22.4M | Buy |
+359,272
| New | +$22.8M | 1.55% | 11 |
|
Other funds holding GSK
BCIM
Confluence Investment Management's GSK Position: Q1 2021 in Review
Confluence Investment Management sold out of GSK (GSK) in Q1 2021, closing a stake of 27,434 shares — an estimated $1.26M sold.
Confluence Investment Management first reported a position in GSK in Q2 2013 and held it in 31 quarters. The position peaked at $83.2M in Q2 2017. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.
- Confluence Investment Management reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
- Confluence Investment Management sold 27,434 GSK shares in Q1 2021, an estimated $1.26M.
- Confluence Investment Management first reported a position in GSK in Q2 2013 and held it in 31 quarters.
- Confluence Investment Management's GSK position peaked at $83.2M in Q2 2017.
- 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.
Based on Confluence Investment Management's 13F filing for Q1 2021, filed 5 Apr 2021.